Thermogenesis Holdings Inc
F:THR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Shenzhen Weiguang Biological Products Co Ltd
SZSE:002880
|
CN |
Thermogenesis Holdings Inc
Total Receivables
Thermogenesis Holdings Inc
Total Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Thermogenesis Holdings Inc
F:THR
|
Total Receivables
$1.1m
|
CAGR 3-Years
11%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-15%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Total Receivables
$2.9B
|
CAGR 3-Years
14%
|
CAGR 5-Years
14%
|
CAGR 10-Years
9%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Total Receivables
$912.1m
|
CAGR 3-Years
9%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
Stryker Corp
NYSE:SYK
|
Total Receivables
$4B
|
CAGR 3-Years
4%
|
CAGR 5-Years
8%
|
CAGR 10-Years
9%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Total Receivables
$7.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
5%
|
CAGR 10-Years
9%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Total Receivables
$1.5B
|
CAGR 3-Years
17%
|
CAGR 5-Years
19%
|
CAGR 10-Years
15%
|
|
Thermogenesis Holdings Inc
Glance View
ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. The company is headquartered in Rancho Cordova, California and currently employs 39 full-time employees. The firm provides the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and CAR-TXpress platform for large scale cell manufacturing services. The company manufactures and markets three categories of products, Clinical Bio-Banking Applications, Point-of-Care Applications, and Large Scale Cell Processing and Biomanufacturing. Its Clinical Bio-Banking Applications includes AXP II Automated Cell Separation System and BioArchive Automated Cryopreservation System. Point-of-Care Applications includes PXP Point-of-Care System, PXP-LAVARE System and PXP-1000 System. Its Large Scale Cell Processing and Biomanufacturing includes X-Series Products for general laboratory useand CAR-TXpress Platform for clinical manufacturing.
See Also
What is Thermogenesis Holdings Inc's Total Receivables?
Total Receivables
1.1m
USD
Based on the financial report for Mar 31, 2024, Thermogenesis Holdings Inc's Total Receivables amounts to 1.1m USD.
What is Thermogenesis Holdings Inc's Total Receivables growth rate?
Total Receivables CAGR 10Y
-15%
Over the last year, the Total Receivables growth was 20%. The average annual Total Receivables growth rates for Thermogenesis Holdings Inc have been 11% over the past three years , -10% over the past five years , and -15% over the past ten years .
